Dr. Robert Whitfield MD

Dr. Robert Whitfield MD Developed the SHARP Method. Office: 2530 Walsh Tarlton Ln Ste 100, Austin, TX 78746

Dr. Robert Whitfield, MD, is a board-certified plastic surgeon based in Austin, Texas, specializing in advanced explant surgery and breast implant illness (BII) recovery. Cosmetic Surgery, EVOKE, EVOLVE, RHA, Injectables, Lip augmentation, Laser treatments, Skin tightening, Hydrafacial, Radiofrequency, FaceTite, Bodytite, SmartGraft Hair Restoration, miraDry, Votiva Vaginal Rejuvenation, Liposuction, Chemical Peels, Microneedling, IPL, Body contouring

09/08/2026

A translational study connected several evidence layers: greater measured biofilm abundance in symptomatic tissue samples, higher 10-HOME levels in a small tissue subset, Th1 polarization in laboratory exposed human cells, and selected immune findings plus fatigue-like behavior in mice. That chain is biologically interesting and testable. It is not final proof that one pathway explains every person, that experimental mouse exposure matches human exposure, or that blocking 10-HOME would improve symptoms. It does not establish a diagnostic test or treatment. Education only. Discuss personal decisions with your provider. Study: https://doi.org/10.1172/JCI165644 Please share this with someone who values careful research translation.

09/08/2026

Our September 3 episode of The Dr. Robert Whitfield Show is out: Episode 184, Biofilm on Breast Implants? What the New BII Research Really Shows.

In this clip, I explain how researchers connected 10-HOME with TH1 immune activation, and why that pathway may help explain inflammatory symptoms in at least some patients with breast implants.

Important: this study does not prove that biofilm or 10-HOME causes every case of BII, and it does not establish a diagnostic test or treatment. It gives us a biologically plausible model that deserves continued study.

Watch on YouTube: https://www.youtube.com/watch?v=HpAgeGcfvo4
Listen on Spotify: https://open.spotify.com/episode/22zdIOJ09W4cfdHdikJfum
Listen on Apple Podcasts: https://podcasts.apple.com/us/podcast/id1678143554?i=1000787742902

Follow The Dr. Robert Whitfield Show and share this episode with someone who needs a more informed conversation about BII.

09/08/2026

The three questions every surgery patient asks. Drains, pain, brain fog.

None of this equipment does surgery. All of it changes recovery.

09/08/2026

When exploring biofilm and capsular contracture, culture and next-generation sequencing answer different questions. Culture attempts to grow organisms under specific conditions. Sequencing can detect microbial DNA, but that detection alone does not establish organism viability, mature biofilm, active infection, diagnosis, causation, or treatment utility.

Let’s make the science easier to understand on Thursday, September 10 at 6 PM CT / 7 PM ET.

Educational only. Individual care belongs with your healthcare provider.

Join the livestream:
https://drrobscircle.com/signup

SOURCE
Whitfield et al. Microorganisms 2024;12:1830.
https://doi.org/10.3390/microorganisms12091830

09/08/2026

The three questions every surgery patient asks. Drains, pain, brain fog.

None of this equipment does surgery. All of it changes recovery.

09/08/2026

To understand a possible relationship between biofilm and capsular contracture, remember that culture and next-generation sequencing answer different questions. Culture attempts to grow organisms under specific laboratory conditions. Sequencing can detect microbial DNA, including when an organism does not grow in culture. But DNA detection cannot tell us, by itself, whether an organism is alive, whether a mature biofilm is present, or whether there is an active infection. Thursday, I will explain why the method changes how we interpret the result.

What did 694 submitted explant capsule and tissue samples reveal about the possible relationship between biofilm and cap...
09/07/2026

What did 694 submitted explant capsule and tissue samples reveal about the possible relationship between biofilm and capsular contracture?

In my published retrospective study, 203 of 694 submitted samples had positive microbiological findings. That is 29% of the submitted samples tested. These were samples from a selected explant population with breast augmentation failure, not 694 patients, and the result is not a prevalence estimate for everyone with breast implants.

Among the positive samples, 103 unique species were detected. Dominant organisms included Cutibacterium acnes, Staphylococcus epidermidis, and Corynebacterium tuberculostearicum.

The testing detected bacterial genetic material. Detection does not, by itself, establish viability, mature biofilm, active infection, diagnosis, causation, or treatment utility.

Join me live Thursday, September 10 at 6 PM CT / 7 PM ET for the findings, the limitations, and your questions.

Educational only. Individual care belongs with your healthcare provider.

Register: https://drrobscircle.com/signup

Source: Whitfield R, et al. Microorganisms. 2024;12:1830. https://doi.org/10.3390/microorganisms12091830

09/07/2026

Biofilm and capsular contracture: 29% of what?

The denominator matters. In this retrospective study of a selected explant population, 203 of 694 submitted explant capsule and tissue samples had positive microbial findings. The 694 refers to samples, not patients, and the result should not be generalized as the rate for everyone with breast implants.

Join the live discussion Thursday, September 10 at 6 PM CT / 7 PM ET.

Register here: https://drrobscircle.com/signup

Educational only. Testing is informational, not diagnostic. Individual care belongs with your healthcare provider.

Source: Whitfield et al. Microorganisms 2024;12:1830. https://doi.org/10.3390/microorganisms12091830

09/07/2026

The study does not prove that 10-HOME causes the complete human BII symptom picture. Human tissue findings were observational. Direct 10-HOME interventions occurred in laboratory cells and mice. Those experiments show biological activity under controlled conditions, but they do not establish a human-equivalent exposure, a validated diagnostic test, or a treatment. The biofilm to 10-HOME to TH1 pathway remains a coherent, testable model rather than a finished clinical answer. Study: https://doi.org/10.1172/JCI165644 Education only. Discuss personal results and treatment decisions with your provider. Please share this with someone who values evidence before conclusions.

09/07/2026

The relationship between biofilm and capsular contracture requires careful interpretation. The denominator matters. In this retrospective study of a selected explant population, 203 of 694 submitted explant capsule and tissue samples had positive microbial findings. The 694 refers to samples, not patients, and the result should not be generalized as the rate for everyone with breast implants.
Join the live discussion Thursday, September 10 at 6 PM CT / 7 PM ET.
Educational only. Testing is informational, not diagnostic. Individual care belongs with your healthcare provider.
Register here:
https://drrobscircle.com/signup
Source:
Whitfield et al. Microorganisms 2024;12:1830.
https://doi.org/10.3390/microorganisms12091830

Address

2530 Walsh Tarlton Lane, Suite 100
Austin, TX
78746

Opening Hours

Monday 10am - 7pm
Tuesday 10am - 7pm
Wednesday 10am - 7pm
Thursday 10am - 7pm
Friday 10am - 5pm

Telephone

+18777852832

Website

Alerts

Be the first to know and let us send you an email when Dr. Robert Whitfield MD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Dr. Robert Whitfield MD:

Shortcuts

Share

Category